June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Quantitative assessment of aqueous flare after DMEK shows persistent subclinical inflammation
Author Affiliations & Notes
  • Lamis Baydoun
    NIIOS, Rotterdam, Netherlands
  • Silke Oellerich
    NIIOS, Rotterdam, Netherlands
  • Fook Chang Lam
    NIIOS, Rotterdam, Netherlands
  • Korine Van Dijk
    NIIOS, Rotterdam, Netherlands
  • Gerrit Melles
    NIIOS, Rotterdam, Netherlands
  • Footnotes
    Commercial Relationships   Lamis Baydoun, DORC International (C); Silke Oellerich, None; Fook Chang Lam, None; Korine Van Dijk, None; Gerrit Melles, DORC International (C), SurgiCube International (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4780. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lamis Baydoun, Silke Oellerich, Fook Chang Lam, Korine Van Dijk, Gerrit Melles; Quantitative assessment of aqueous flare after DMEK shows persistent subclinical inflammation. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4780.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : With Descemet membrane endothelial keratoplasty (DMEK) less antigenic tissue is transplanted as compared to penetrating keratoplasty. Even though eyes after DMEK may look clinically quiet, there may still be some subclinical inflammation induced by the DMEK transplant. Therefore, we wanted to objectively quantify aqueous flare as a measure of intraocular inflammation in DMEK eyes.

Methods : 148 DMEK eyes of 148 patients operated on for Fuchs endothelial dystrophy and 19 age-matched healthy control eyes were included in this comparative cross-sectional case series at a tertiary referral center. Aqueous flare was assessed by laser flare photometry on average 27 (±19) months after DMEK (range: 3 - 86 months, median 24 months) and was compared to control eyes.

Results : Average flare was higher in DMEK eyes compared to the healthy controls (9.4 photon count per millisecond (ph/ms), (95% Confidence Interval (CI) 8.7-10.1) versus 6.7 ph/ms (CI 4.5-8.9), respectively (P=.0246), estimated mean difference: -2.71 (CI -5.1-0.35)). Age was significantly associated with flare (P=.0138). For the DMEK group, gender, lens status, presence of diabetes, follow-up time and endothelial cell density were not related to the flare level (P>.05).

Conclusions : Higher aqueous flare levels after DMEK may indicate a persistent subclinical inflammation. Ongoing topical anti-inflammatory treatment may therefore be beneficial. Laser flare photometry may be a potential diagnostic tool to monitor intraocular inflammation levels following DMEK in order to adjust treatment accordingly.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.